Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 DiabetesRajiv Agarwal, Anantharaman Vathsala, Sanjay Kaul et al.|Annals of Internal Medicine|2023Cited by 94
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD StudyJanusz Gumprecht, Ellen Burgess, Rajiv Agarwal et al.|Diabetes Care|2022Cited by 36
Real-world characteristics, modern antidiabetic treatment patterns, and comorbidities of patients with type 2 diabetes in central and Eastern Europe: retrospective cross-sectional and longitudinal evaluations in the CORDIALLY® studyMartin Prázný, Milos Aleksandric, Л. А. Суплотова et al.|Cardiovascular Diabetology|2022Cited by 11